Long-Term Specified Drug Use-Results Survey for Xtandi Capsule

Study of ORIC-101 in Combination With Enzalutamide

NCT04033328 ·Status: TERMINATED ·Phase: PHASE1

Personalizing Enzalutamide Therapy by Understanding the Relation Between Tumor mRNAs, miRNAs and Treatment Response

NCT02471469 ·Status: COMPLETED

Enzalutamide for Bladder Cancer Chemoprevention

NCT02605863 ·Status: TERMINATED ·Phase: PHASE2

Comparative Study of Alternative Antiandrogen (AA) Therapy and Early Initiating of Enzalutamide for Castration-resistant Prostate Cancer (CRPC) After Combined Androgen Blockade (CAB) Therapy.

NCT02346578 ·Status: COMPLETED ·Phase: PHASE2

Imaging Staging and Response Prediction in Metastatic Hormono-Sensitive Prostate Cancer Patients Receiving Enzalutamide

NCT02815033 ·Status: COMPLETED ·Phase: PHASE2

Dynamics of Androgen Receptor Genomics and Transcriptomics After Neoadjuvant Androgen Ablation

NCT03297385 ·Status: COMPLETED ·Phase: PHASE2

Phase II Study of ASP3550 in Patients With Prostate Cancer

NCT00568516 ·Status: COMPLETED ·Phase: PHASE2

A Study of Androgen Receptor (AR) Antagonist Apalutamide in Chinese Participants With Metastatic Castration-Resistant Prostate Cancer

NCT03523442 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Japanese Research for Patients With Non-metastatic Castration Resistant Prostate Cancer - Enzalutamide

NCT02588001 ·Status: COMPLETED ·Phase: NA

Study to Find Maintenance Dose for Periodic Administration of ASP3550

NCT01261572 ·Status: COMPLETED ·Phase: PHASE2

Docetaxel, Estramustine and Short Term Androgen Withdrawal for Patients With a Rising PSA After Local Treatment

NCT00165399 ·Status: COMPLETED ·Phase: PHASE2

Genetic and Molecular Mechanisms in Assessing Response in Patients With Prostate Cancer Receiving Enzalutamide Therapy

NCT02099864 ·Status: COMPLETED ·Phase: PHASE2

A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study

NCT02960022 ·Status: RECRUITING ·Phase: PHASE2

Safety and Efficacy of Oral Testosterone Undecanoate Followed by Enzalutamide as Therapy for Men With Metastatic Castrate Resistant Prostate Cancer

NCT05081193 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Safety and Efficacy of Enzalutamide in Chemotherapy-Naïve, Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer

NCT01663415 ·Status: WITHDRAWN ·Phase: PHASE2

Study of Enzalutamide (Formerly MDV3100) as a Neoadjuvant Therapy for Patients Undergoing Prostatectomy for Localized Prostate Cancer

NCT01547299 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate Exicorilant (CORT125281) in Combination With Enzalutamide in Patients With Metastatic Castration-Resistant Prostate Cancer

NCT03437941 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Phase II Randomised Controlled Trial of Patient-specific Adaptive vs. Continuous Abiraterone or eNZalutamide in mCRPC

NCT05393791 ·Status: RECRUITING ·Phase: PHASE2

A Study of MDV3100 to Evaluate Safety, Tolerability, Pharmacokinetics and Efficacy of in Prostate Cancer Patients

NCT01284920 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

NCT01288911 ·Status: COMPLETED ·Phase: PHASE2

Dose-Finding Study of Afuresertib Administered in Combination With Either Enzalutamide or Aibraterone

NCT02380313 ·Status: WITHDRAWN ·Phase: PHASE1

A Study to Monitor the Safety of Enzalutamide in Patients With Progressive Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy

NCT02124668 ·Status: COMPLETED ·Phase: PHASE2

Safety Study of Continued Enzalutamide Treatment In Prostate Cancer Patients

NCT01995513 ·Status: COMPLETED ·Phase: PHASE4

Combination of Entinostat and Enzalutamide in Advanced Prostate Cancer

NCT03829930 ·Status: TERMINATED ·Phase: PHASE1

Safety and Efficacy Study of Enzalutamide Versus Bicalutamide in Men With Prostate Cancer

NCT01664923 ·Status: COMPLETED ·Phase: PHASE2